Skip to Main Content
Boston University
  • Bostonia
  • BU Today
  • The Brink
  • University Publications

    • Bostonia
    • BU Today
    • The Brink
  • School & College Publications

    • The Record
Other Publications
BU Today
  • Sections
News, Research, Community

No more needles

Programming cells to heal the body

 

Hormonal therapies – such as insulin for diabetics, human growth hormone for people with dwarfism, and interferon for fighting tumors or hepatitis – are expensive to manufacture. They have one other shortcoming: They work only if patients follow through with the treatments, which often means multiple daily injections.

While advancements have been made, from infusion pumps to inhalants, injections are still the standard of care, according to Michael Wolfe, a School of Medicine professor of medicine and chief of the gastroenterology section at Boston Medical Center. And all those needles lead to significant “noncompliance rates” among patients.

“Injections hurt,” Wolfe says simply. “They’re uncomfortable and inconvenient.” He and his research team are working on a new means of both manufacturing and delivering hormonal therapies – using the patient’s own cells. Specifically, they are working on genetically modifying a patient’s stem cells (derived from fat or bone marrow) into little hormone “factories” that can be reimplanted into the patient to create the needed treatments.  

Wolfe and his research team have successfully engineered stem cells to produce human insulin in the stomach and small intestine of mice, and now their efforts have garnered one of three Ignition Awards from BU’s Office of Technology Development (OTD), each worth about $50,000.  

Four times a year, with the help of a five–person committee of senior venture capitalists from the Boston area, OTD selects Ignition Award winners from applications submitted by BU professors or students whose research is ready to make the leap from the laboratory to the business world.

“The Ignition Awards program exists to recognize research that will someday translate into commercially available technologies, products, or treatments,” says Stanford Willie, executive director of OTD. “This first batch of winning projects represents diverse and potentially lifesaving applications in health and medicine.”

To view Part 1 of the Ignition Award series, Sniffing Out Cancer, click here.

To view Part 2, Solving the Pain Puzzle, click here.

Explore Related Topics:

  • Faculty
  • Research
  • Share this story

Share

No more needles

Share

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email

Latest from BU Today

  • Students

    Eight Boston Experiences Every BU First-Year Should Try

  • Students

    Where to Eat When You’re Hungry at BU

  • Scholarships

    Boston University’s 2026 Menino Scholars and Community Leaders Scholars Arrive Ready to Change Their World

  • 10 BU Hacks Every Terrier Should Know

  • Student Life

    Everything You Need to Know about Splash (and Why You Should Attend)

  • Film & TV

    “Tony” – Anthony Bourdain Biopic of Iconic Chef and TV Host

  • Your Guide to BU Student Discounts, Freebies, and Terrier Card Perks

  • This Weekend @ BU: September 3 to 7

  • Clubs

    Design, Build, Drive: Meet Terrier Motorsport

  • Meet Boston University’s New Provost, Colin Duckett

  • International Students

    Your First Year at BU: A Guide for International Students

  • University News

    Boston University Matriculation 2026: Welcome Class of 2030!

  • Marine Science

    Marine Science Career Accelerator Helps Student Careers

  • Campus Life

    Move-in 2026 Photo Gallery

  • Campus Life

    Video Captures the Emotion of Move-In

  • Engineering

    Research Program for Boston High School Teachers

  • Internship

    Student Interns Learn What Makes Municipal Government Work

  • Faculty

    Opening Up the World of Writing to Boston University’s Medical Campus Faculty

  • Arts & Culture

    Wheelock Family Theatre Gives High School Students a Hands-On Role in Theater Management

  • Social Media

    BU Expert on Meta’s $17.1 Billion Settlement Over Social Media Addiction Claims

Section navigation

  • Sections
  • Must Reads
  • Videos
  • Series
  • Close ups
  • Archives
  • About + Contact
Get Our Email

Explore Our Publications

Bostonia

Boston University’s Alumni Magazine

BU Today

News, Research, Community

The Brink

Pioneering Research from Boston University

  • Twitter
  • Facebook
  • Youtube
  • LinkedIn
  • Instagram
  • Weibo
  • TikTok
© Boston University. All rights reserved. www.bu.edu
© 2026 Trustees of Boston UniversityPrivacy StatementAccessibility
Boston University
Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, age, national origin, ethnicity, shared ancestry and ethnic characteristics, physical or mental disability, sexual orientation, gender identity and/or expression, genetic information, pregnancy or pregnancy-related condition, military service, marital, parental, veteran status, or any other legally protected status in any and all educational programs or activities operated by Boston University. Retaliation is also prohibited. Please refer questions or concerns about Title IX, discrimination based on any other status protected by law or BU policy, or retaliation to Boston University’s Executive Director of Equal Opportunity/Title IX Coordinator, at titleix@bu.edu or (617) 358-1796. Read Boston University’s full Notice of Nondiscrimination.
Search
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
No more needles
0
share this